-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS, - TREATMENT TO CONTINUE TO 52 WEEKS; BLA SUBMISSION PLANNED FOR 2027

Reuters·09/22/2026 11:00:09